Status:
UNKNOWN
Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line
Lead Sponsor:
Cairo University
Conditions:
Tongue Neoplasms
Carcinoma
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
In vitro study to examine whether luteolin and nano-luteolin exert an inhibitory effect on tongue squamous cell carcinoma cell line by inducing apoptosis, and to assess if nano-luteolin has more effic...
Detailed Description
This study is conducted to examine whether luteolin and nano-luteolin exert an inhibitory effect on tongue squamous cell carcinoma cell line by inducing apoptosis, and to assess if nano-luteolin has m...
Eligibility Criteria
Inclusion
- Squamous cell carcinoma cell lines (OSCC, TSCC and HNSCC).
- Luteolin 5,7,3',4'-tetrahydroxy-flavone (MeSH term).
- Application of luteolin as a chemotherapeutic drug.
Exclusion
- Any cancer cell line other than OSCC, TSCC and HNSCC cell lines.
- Luteolin glycosides.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03288298
Start Date
November 1 2017
End Date
April 1 2019
Last Update
September 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.